Autologous Transfusion In Surgery: a randomised clinical trial

Completed

• Conditions: Cardiovascular diseases: Peripheral arterial disease; Circulatory System; Peripheral arterial disease

• Registration Number: ISRCTN85756518
• Lead Sponsor: HS R&D Regional Programme Register - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01-23
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 0

Inclusion Criteria

All patients undergoing elective surgery for either occlusive or aneurysmal arterial disease will be asked to give written informed consent:
1. Both men and women aged 30-85
2. Considered fit for aortic surgery without any of the exclusion criteria
3. Pre-operative haemoglobin >11 g/dl and platelet count >150 x 10^9/1
4. Adequate cardiac and pulmonary function clinically

Exclusion Criteria

Any patient unfit for aortic surgery, unable for any reason to receive either autologous or standard transfusion therapy, or undergoing emergency surgery for suspected rupture of an aneurysm.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood transfusion requirements, haematological and haemostatic parameter, post-operative infection, morbidity and hospital stay, economic analysis

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration